| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-C motif chemokine receptor 5 (gene/pseudogene) | 0.398 | 0.885 | 4.3E-10 |
|
disease | 0.280 | None | 0.889 | 8 | 0 | 2004 | 2016 | ||||||||
|
CD40 ligand | 0.414 | 0.846 | 0.72 |
|
disease | 0.240 | None | 1.000 | 3 | 0 | 2008 | 2019 | ||||||||
|
macrophage migration inhibitory factor | 0.412 | 0.885 | 1.2E-02 |
|
disease | 0.230 | None | 1.000 | 2 | 1 | 2006 | 2015 | ||||||||
|
cholesteryl ester transfer protein | 0.512 | 0.731 | 1.2E-23 |
|
disease | 0.200 | None | 0.947 | 91 | 6 | 1990 | 2020 | ||||||||
|
proprotein convertase subtilisin/kexin type 9 | 0.482 | 0.808 | 2.7E-17 |
|
disease | 0.200 | None | 0.986 | 72 | 6 | 2006 | 2020 | ||||||||
|
ATP binding cassette subfamily A member 1 | 0.467 | 0.846 | 1.5E-13 |
|
disease | 0.200 | None | 0.960 | 47 | 10 | 2000 | 2019 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
disease | 0.200 | None | 1.000 | 24 | 14 | 2007 | 2020 | |||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.200 | None | 1.000 | 18 | 3 | 2010 | 2020 | ||||||||
|
phosphatase and actin regulator 1 | 0.663 | 0.423 | 0.64 |
|
disease | 0.200 | None | 1.000 | 16 | 2 | 2011 | 2019 | ||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
disease | 0.200 | None | 0.938 | 15 | 0 | 1980 | 2019 | |||||||||
|
lipase C, hepatic type | 0.585 | 0.654 | 3.3E-07 |
|
disease | 0.200 | None | 0.941 | 15 | 2 | 1997 | 2016 | ||||||||
|
arachidonate 5-lipoxygenase | 0.447 | 0.885 | 1.2E-06 |
|
disease | 0.190 | None | 0.900 | 9 | 0 | 2005 | 2019 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.190 | None | 1.000 | 9 | 1 | 2004 | 2018 | ||||||||
|
interleukin 6 receptor | 0.471 | 0.846 | 3.2E-05 |
|
disease | 0.190 | None | 1.000 | 9 | 3 | 2009 | 2020 | ||||||||
|
transcription factor 21 | 0.537 | 0.692 | 0.83 |
|
disease | 0.190 | None | 0.909 | 9 | 1 | 2011 | 2019 | ||||||||
|
ADAM metallopeptidase with thrombospondin type 1 motif 7 | 0.666 | 0.577 | 2.3E-14 |
|
disease | 0.180 | None | 1.000 | 8 | 0 | 2011 | 2019 | ||||||||
|
phospholipid phosphatase 3 | 0.722 | 0.192 | 0.92 |
|
disease | 0.180 | None | 1.000 | 8 | 4 | 2011 | 2019 | ||||||||
|
scavenger receptor class B member 1 | 0.559 | 0.731 | 6.6E-02 |
|
disease | 0.180 | None | 1.000 | 8 | 8 | 2003 | 2018 | ||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
disease | 0.170 | None | 1.000 | 7 | 1 | 2003 | 2017 | |||||||||
|
lipase A, lysosomal acid type | 0.564 | 0.654 | 5.5E-07 |
|
disease | 0.160 | None | 1.000 | 6 | 3 | 2003 | 2019 | ||||||||
|
fatty acid desaturase 1 | 0.582 | 0.769 | 0.37 |
|
disease | 0.160 | None | 1.000 | 6 | 2 | 2010 | 2018 | ||||||||
|
solute carrier family 22 member 3 | 0.531 | 0.846 | 7.8E-10 |
|
disease | 0.160 | None | 1.000 | 6 | 1 | 2009 | 2017 | ||||||||
|
lipoprotein(a) like 2, pseudogene | 0.626 | 0.731 |
|
disease | 0.160 | None | 1.000 | 6 | 0 | 1991 | 2017 | |||||||||
|
nuclear receptor subfamily 1 group H member 3 | 0.566 | 0.692 | 0.90 |
|
disease | 0.150 | None | 0.833 | 5 | 1 | 2006 | 2014 | ||||||||
|
collagen type IV alpha 2 chain | 0.563 | 0.654 | 3.6E-15 |
|
disease | 0.150 | None | 0.857 | 5 | 1 | 2011 | 2018 |